Clinical Trials Logo

Influenza, Avian clinical trials

View clinical trials related to Influenza, Avian.

Filter by:
  • None
  • Page 1

NCT ID: NCT03745274 Completed - Influenza, Avian Clinical Trials

Two Doses of GHB04L1 for Pandemic Influenza Prophylaxis in Healthy Adults

Start date: December 19, 2008
Phase: Phase 1
Study type: Interventional

This study evaluates safety, tolerability and immunogenicity of two doses of GHB04L1, a liquid formulation of the replication- deficient influenza A/Vietnam/1203/04(H5N1)-like ∆NS1 virus in healthy adults. Subjects are randomised at a ratio of 2:1 for GHB04L1 (6.8 log10 or 7.5 log10 TCID50/dose/volunteer) or placebo.

NCT ID: NCT03038776 Completed - Influenza, Avian Clinical Trials

Recombinant H7 Hemagglutinin Influenza Vaccine Trial

FLU007
Start date: January 2017
Phase: Phase 1
Study type: Interventional

Recombinant H7 (rH7) vaccine has been shown to be poorly immunogenic in previous human clinical trials. This study will test approaches to improve the immunogenicity of H7 vaccine, namely use of a three dose regimen, use of a modified H7 HA sequence from which the Tregitope has been removed (rH7m), and inclusion of delta inulin adjuvant adjuvant in the vaccine

NCT ID: NCT01052402 Completed - Influenza, Avian Clinical Trials

Safety and Immunogenicity Study of a H5N1 Influenza Vaccine (Vero Cell-Derived, Whole Virus) in Healthy Infants, Children and Adolescents

Start date: December 2009
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to assess the safety and immunogenicity (i.e. primary immune response, immunogenicity of two different doses, antibody persistence 360 days after the first vaccination, immune response to a heterologous booster given on Day 360) of a Vero cell-derived whole virus H5N1 influenza vaccine in healthy infants, children and adolescents aged 6 months to 17 years.